Skip to content

Illumina Partnerships

Partnership Discussions

Collaborating to Advance Genomics

As a global leader in genomics, we continually strive to offer solutions that are not only innovative, but also accessible and always reliable. Illumina partnerships help advance genomics in numerous ways, from expanding access to next-generation sequencing (NGS) to pioneering new applications and technologies, providing funding for innovative startups, and more. 

Featured Pharmaceutical & Biotech Partnerships

Some of our existing partnerships include:

Roche

Illumina and Roche partner to broaden the adoption of distributable next-generation sequencing-based testing in oncology.

Read Press Release
Bristol-Myers Squibb, Merck, Kura, & Myriad

Illumina forms multiple partnerships to develop precision oncology solutions.

Read Press Release
Loxo Oncology

Illumina and Loxo Oncology partner to develop next-generation sequencing-based pan-cancer companion diagnostics.

Read Press Release

Additional Partnerships

Discover more Illumina partnerships and collaborations designed to advance access to groundbreaking genomics solutions.

Illumina & IDbyDNA Partner to Deliver Infectious Disease Solutions

The partnership aims to accelerate NGS adoption for clinical infectious disease testing.

Illumina & QIAGEN Partner on Sequencing-Based Diagnostic Tests

The partnership focuses on commercializing oncology In Vitro Diagnostc (IVD) kits to support patient management and may expand to other clinical fields in the future.

Illumina and the Broad Institute Co-develop Secondary Analysis Tools

The partnership involves integrating Illumina DRAGEN Pipelines and technology with the Broad’s Genome Analysis Toolkit (GATK) to develop new methods.

Illumina and AWS Partnership

The partnership supports genomic analysis customers with innovative and secure, cloud-based data processing, management, and storage.

Handshake
Illumina Mergers & Acquisitions

We strive to offer the best possible technologies and solutions to our customers. By integrating our technology with other best-in-class solutions, we aim to improve workflows, support groundbreaking research, and continue advancing genomics.

Learn More
Illumina Accelerator

Startup Funding for Genomics Companies

With mentorship, financial support, and access to sequencers and reagents, the Illumina Accelerator is helping genomics startups launch so we can unlock the power of the genome—together.

Illumina Accelerator Startup Funding